https://www.healthcaretribunefrance.com/article/913649221-studyfetch-launches-honen-for-enterprise-an-agentic-learning-platform-that-builds-training-in-minutes Healthcare Tribune France en PressRelease 2026-05-19T17:12:47+00:00 StudyFetch Launches Honen for Enterprise: An Agentic Learning Platform That Builds Training in Minutes https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861181-honen-logo-1600x836.jpeg https://www.healthcaretribunefrance.com/article/913510757-data-from-immunophotonics-phase-1b-2a-clinical-trial-to-be-presented-at-asco-2026 Healthcare Tribune France en PressRelease 2026-05-19T12:15:00+00:00 Data from Immunophotonics Phase 1b/2a Clinical Trial to Be Presented at ASCO 2026 https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/5902492-logo-2400x776.png https://www.healthcaretribunefrance.com/article/913393191-scw-ai-and-simtra-biopharma-solutions-announce-co-innovation-partnership-for-digital-factory-transformation Healthcare Tribune France en PressRelease 2026-05-19T12:07:54+00:00 SCW.AI and Simtra BioPharma Solutions Announce Co-Innovation Partnership for Digital Factory Transformation https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859383-scw-ai-x-simtra-biopharma-solut-2400x1256.png https://www.healthcaretribunefrance.com/article/913583253-healthai-launches-report-on-eu-ai-act-implementation-for-health-competitiveness Healthcare Tribune France en PressRelease 2026-05-19T10:03:41+00:00 HealthAI Launches Report on EU AI Act Implementation for Health & Competitiveness https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24860627-harnessing-ai-for-health-and-ec-1024x768.jpeg https://www.healthcaretribunefrance.com/article/913669891-ipsen-announces-late-breaking-data-from-first-head-to-head-study-comparing-dysport-and-botox-in-adults-with-upper-limb-spasticity Healthcare Tribune France en PressRelease 2026-05-19T19:00:00+00:00 Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ipsen-notified-website-1200x628pix-500kb-max-jpg.jpg https://www.healthcaretribunefrance.com/article/913669898-ipsen-annonce-des-donn-es-late-breaking-issues-de-la-premi-re-tude-comparative-directe-entre-dysport-et-botox-chez-des-adultes-atteints-de Healthcare Tribune France en PressRelease 2026-05-19T19:00:00+00:00 Ipsen annonce des données « late-breaking » issues de la première étude comparative directe entre Dysport® et Botox® chez des adultes atteints de spasticité du membre supérieur https://ml-eu.globenewswire.com/media/81292fcc-6b3a-4e4a-a083-ea4191bf920a/small/ https://www.healthcaretribunefrance.com/article/913590077-genosafe-advances-clia-pathway-for-transatlantic-atmp-development Healthcare Tribune France en PressRelease 2026-05-19T09:00:00+00:00 GenoSafe advances CLIA pathway for transatlantic ATMP development https://ml-eu.globenewswire.com/media/72bb1656-3d66-4582-bec0-f3fe365d3415/small/teams-zoom-background-helio-v2-png.png https://www.healthcaretribunefrance.com/article/913590088-hephaistos-pharma-appoints-stephan-braun-as-chief-medical-officer-to-lead-clinical-development-strategy Healthcare Tribune France en PressRelease 2026-05-19T09:00:00+00:00 HEPHAISTOS-Pharma appoints Stephan Braun as Chief Medical Officer to lead clinical development strategy https://ml-eu.globenewswire.com/media/2d199475-8ee7-40a8-b726-1f77bc1f8079/small/hephaistos-logo-medium-png.png https://www.healthcaretribunefrance.com/article/913425544-next-generation-sequencing-market-set-to-significantly-grow-from-2026-to-2033-hoffmann-la-roche-ltd-qiagen Healthcare Tribune France en PressRelease 2026-05-18T12:03:14+00:00 Next Generation Sequencing Market Set to Significantly Grow from 2026 to 2033 | Hoffmann-La Roche Ltd, QIAGEN https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24859447-next-generation-sequencing-mark-968x968.jpeg https://www.healthcaretribunefrance.com/article/913408877-kfsh-joins-world-economic-forum-annual-health-roundtable-2026-to-advance-global-dialogue-on-ai-in-healthcare Healthcare Tribune France en PressRelease 2026-05-18T09:30:35+00:00 KFSH Joins World Economic Forum Annual Health Roundtable 2026 to Advance Global Dialogue on AI in Healthcare https://www.healthcaretribunefrance.com/article/913491544-press-release-ats-phase-2-data-demonstrate-the-superiority-of-efdoralprin-alfa-over-a-standard-of-care-augmentation-therapy-in-achieving-higher-faat Healthcare Tribune France en PressRelease 2026-05-18T19:30:00+00:00 Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD   https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.healthcaretribunefrance.com/article/913491550-communiqu-de-presse-ats-les-donn-es-de-phase-2-d-montrent-la-sup-riorit-de-l-efdoralprin-alfa-par-rapport-au-traitement-de-substitution-standard Healthcare Tribune France en PressRelease 2026-05-18T19:30:00+00:00 Communiqué de presse : ATS : Les données de phase 2 démontrent la supériorité de l'efdoralprin alfa par rapport au traitement de substitution standard pour atteindre des taux de fAAT plus élevés dans le DAAT https://ml-eu.globenewswire.com/media/06da731a-67a1-4258-939f-6ef0531ee3bf/small/sanofi-new-logo-jpg.jpg https://www.healthcaretribunefrance.com/article/912523931-abl-diagnostics-announces-strategic-ai-roadmap-to-advance-molecular-research-and-global-data-security Healthcare Tribune France en PressRelease 2026-05-18T06:00:00+00:00 ABL Diagnostics Announces Strategic AI Roadmap to Advance Molecular Research and Global Data Security